Evidence map›Paper›PMID 25710803›Full record

ReviewClinical journal of the American Society of Nephrology : CJASN2015

Infection prevention and the medical director: uncharted territory.

Toros Kapoian, Klemens B Meyer, Douglas S Johnson

Abstract readReview
In one paragraph

Review in Clinical journal of the American Society of Nephrology : CJASN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Toros KapoianAssociate Professor of Medicine, Rutgers-Robert Wood Johnson Medical School, Department of Medicine, Division of Nephrology New Brunswick, New Jersey; Medical Director, Dialysis Clinic, Inc., North Brunswick, New Jersey;
Klemens B MeyerProfessor of Medicine, Division of Nephrology, Tufts University School of Medicine, Medford, Massachusetts; Director, Dialysis Services, Tufts Medical Center, Boston, Massachusetts; and.
Douglas S JohnsonVice-Chairman of the Board, Dialysis Clinic Inc., Nashville, Tennessee doug.johnson@dciinc.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections continue to be a major cause of disease and contributor to death in patients on dialysis. Despite our knowledge and acceptance that hemodialysis catheters should be avoided and eliminated, most patients who begin dialysis initiate treatment through a central vein hemodialysis catheter. Dialysis Medical Directors must be the instrument through which our industry changes. We must lead the charge to educate our dialysis staff and our dialysis patients. We must also educate ourselves so that we not only know that our facility policies are consistent with the best evidence available, but we must also know where local and federal regulations differ. When these differences impact on patient care, we must speak out and have these regulations changed. But it is not enough to know the rules and write them. We must lead by example and show our patients, our nephrology colleagues and our dialysis staff that we always follow these same policies. We need to practice what we preach and be willing and available to redirect those individuals who have difficulty following the rules. In order to effectively change process meaningful data must be collected, analyzed and acted upon. Dialysis Medical Directors must direct and lead the quality improvement process. We hope this review provides Dialysis Medical Directors with the necessary tools to effectively drive this process and improve care.

Indexed as

Physician ExecutivesAmbulatory Care FacilitiesCatheter-Related InfectionsEquipment ContaminationHand HygieneHumansInfection ControlLeadershipOrganizational PolicyPatient Education as TopicRenal DialysisVaccinationchronic dialysischronic hemodialysisdialysis accessimmunologyvascular access

Identifiers

PMID25710803
PMCPMC4422234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.